The H1N1 A/Beijing/262/95 solution contains STE, 0.09% sodium azide (NaN3) and 0.005% thimerosal. Stir thoroughly prior to its use.
Purity:
Greater than 90.0% as determined by SDS-PAGE.
Form:
Opaque suspension.
Application Notes:
Application Notes: Inactivation: Thimerosal and beta propiolactone treatmentThis product has been treated in a manner consistent with methods of inactivation. Generally accepted good laboratory practices appropriate to microbiological/viral safe handling practices and techniques are required at work. Immunological Activity: Serological studies of influenza A virus, immunogen for antibody production.Tested with anti-influenza A monoclonal antibodies in ELISA
* VAT and and shipping costs not included. Errors and price changes excepted